Health IT

Redox partners with Salesforce Health Cloud to expand reach

“Most of our prior visibility in the industry has been startup focused–raising money, accelerators, etc. I think this ups the game just as Redox is ready to support larger and more established software vendors like Salesforce,” said Redox Co-founder and President Niko Skievaski.

Thinking As A Team For Success converge ideas convergenceRedox has inked a partnership deal with Salesforce’s Health Cloud, which becomes widely available today, according to a company statement. The move will boost the reach of the health IT startup formed by ex Epic employees.

Redox developed an API to provide a means to streamline how clinical data is shared and that data can be more easily integrated into health systems, especially those with disparate electronic health records. The ultimate goal is to make healthcare less fragmented. The company’s API integrates with electronic medical records and standardizes disparate data formats to consistent JSON data models.

In response to emailed questions, Redox Co-founder and President Niko Skievaski said getting a buy in from a large, established company like Salesforce is huge.

“Most of our prior visibility in the industry has been startup focused–raising money, accelerators, etc. I think this ups the game just as Redox is ready to support larger and more established software vendors like Salesforce.”

He added: “The thing I love most about this partnership is that the Salesforce Health Cloud product is exactly the type of application we designed Redox for. Working with Health Cloud didn’t require us to do custom development and fit within how we envisioned software vendors wanting to exchange data with EHRs.”

Redox was one of a handful of health IT companies partnering with Salesforce on its health cloud.

Last fall, Redox raised $3.5 million to help it grow its network of integrated health systems and applications.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Photo: BigStock Photos